Eczema Awareness Monthly – An American Academy of Dermatology Official Licensee
0
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
0
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Advertisement
EczemaStudies

The role of thymus and activation-regulated chemokine as a marker of severity of atopic dermatitis

Awareness Monthly
Posted by Awareness Monthly

The aspects of serum thymus and activation-regulated chemokine (TARC) was studied to assess severity and QoL in patients with atopic dermatitis.

Learn more at the Journal of the American Academy of Dermatology.

Share on
Share on Facebook Share on Twitter Share on Pinterest Share on Email
Awareness Monthly
Previous Article Types and treatments: Stasis dermatitis
Next Article Insider secrets: Nickel allergy: How to avoid exposure and reduce symptoms
Advertisement

 

Advertisement

 

You Might Also Enjoy

EczemaStudies

Examining the Use of Systemic Immunomodulating Medications in Pregnant Women with Atopic Dermatitis

EczemaStudies

Exploring the Risk of Skin Cancer from Ultraviolet B Phototherapy for the Treatment of Atopic Dermatitis

EczemaStudies

Atopic Dermatitis: Review Provides an Updated Overview of Emerging Treatments for Itch

EczemaStudies

Researchers Seek to Uncover the Impact of Atopic Dermatitis on Alopecia Areata

Load More
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee

© 2020-2023 Powered by eHealthcare Solutions | Privacy Policy

×